Newsletter

Sign up for our newsletter

Latest Publications

Latest publications

EC Committee Adopts Opinion on Assessing the Risks of Nanotechnology

On February 18, 2009, the European Commission (EC) Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) published its opinion on the most recent developments in the risk assessment of nanomaterials.
Read more

NIOSH Offers Interim Guidance For Worker Medical Screening, Hazard Surveillance Pertaining To Engineered Nanoparticles

On February 13, 2009, the National Institute for Occupational Safety and Health (NIOSH) announced the availability of “Current Intelligence Bulletin 60: Interim Guidance for the Medical Screening and Hazard Surveillance for Workers Potentially Exposed to Engineered Nanoparticles.”
See http://www.cdc.gov/niosh/docs/2009-116/

Project on Government Oversight: The FDA's Deadly Gamble with the Safety of Medical Devices

On January 18, 2009, the Project on Government Oversight published a report pointing out FDA’s showing the agency deliberately backed off of "Good Laboratory Practice" requirements for medical device makers. In doing so, the agency allowed device companies to test their products on humans without proving that the tests adhered to standards observed for three decades.
See http://www.pogo.org/pogo-files/reports/public-health/safety-of-medical-d...

GAO Report: FDA Should Take Steps to Ensure That High-Risk Device Types Are Approved through the Most Stringent Premarket Review Process

FDA scientists complained to President-elect Obama about less-than-rigorous oversight at the agency, especially for medical devices. Now, the Government Accountability Office is saying that hundreds of devices got the FDA nod without a full-scale review.
See http://www.gao.gov/new.items/d09190.pdf

PEN Report: A Hard Pill To Swallow: Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements

On January 14, 2009, the Project on Emerging Nanotechnologies (PEN) released a report entitled A Hard Pill To Swallow: Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements (see attached), which describes problems at the Food and Drug Administration (FDA) in regulating nano-enabled dietary supplements and offers recommendations for improving oversight.
See http://www.nanotechproject.org/publications/archive/pen17/

EPA Interim Report on the Nanoscale Materials Stewardship Program

On January 12, 2009, the U.S. Environmental Protection Agency (EPA) released its interim report on the Nanoscale Materials Stewardship Program (NMSP), which is a voluntary program that EPA established to assemble existing data and information from manufacturers and processors of certain nanoscale materials.
See http://www.epa.gov/oppt/nano/nmsp-interim-report-final.pdf

Good uses of nanomaterials in the Netherlands (survey report)

Results of a survey by Hogeschool Zuyd, Centre of Expertise in Life

Sciences , Arbo Unie, Expertise Centrum Toxische Stoffen (ECTS),

and ARBOdienst DSM, Geleen to obtain an overview of the current good practices using engineered nanoparticles, and the associated occupational hygiene measures, instructions, communication in the economic chain and the disposal of nanoparticle-containing waste.

See http://www.nano4all.nl/Reporshortsummary.pdf

IRGC Report on Risk Governance

On 18 December 2008, International Risk Governance Council published the report “Risk Governance of Nanotechnology Applications in Food and Cosmetics” prepared for IRGC by Antje Grobe, Ortwin Renn and Alexander Jaeger of Dialogik GmbH

See http://www.irgc.org/IMG/pdf/Nanotechnology_Report.pdf

Syndicate content